VEA
GTHX

Virtus ETF Advisers’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Virtus ETF Advisers’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,188
Closed -$115K – 485
2022
Q1 		$115K Sell
15,188
-900
-6% -$8.54K 0.05% 280
2021
Q4 		$164K Buy
16,088
+6,745
+72% +$86K 0.06% 315
2021
Q3 		$125K Sell
9,343
-489
-5% -$7.97K 0.06% 369
2021
Q2 		$216K Sell
9,832
-5,487
-36% -$122K 0.09% 287
2021
Q1 		$369K Buy
15,319
+264
+2% +$6.13K 0.16% 197
2020
Q4 		$271K Sell
15,055
-1,658
-10% -$24.8K 0.11% 273
2020
Q3 		$193K Sell
16,713
-2,278
-12% -$37.6K 0.1% 301
2020
Q2 		$461K Buy
18,991
+4,428
+30% +$73.2K 0.22% 161
2020
Q1 		$160K Sell
14,563
-2,121
-13% -$39.6K 0.07% 285
2019
Q4 		$441K Buy
16,684
+3,081
+23% +$72.1K 0.07% 226
2019
Q3 		$310K Sell
13,603
-757
-5% -$23.9K 0.06% 196
2019
Q2 		$440K Buy
14,360
+5,706
+66% +$120K 0.09% 190
2019
Q1 		$144K Sell
8,654
-1,300
-13% -$24.7K 0.31% 95
2018
Q4 		$191K Sell
9,954
-607
-6% -$22.7K 0.03% 179
2018
Q3 		$552K Sell
10,561
-7,542
-42% -$411K 0.06% 113
2018
Q2 		$787K Sell
18,103
-20,022
-53% -$858K 0.7% 38
2018
Q1 		$1.41M Buy
38,125
+20,478
+116% +$546K 1.23% 8
2017
Q4 		$350K Buy
+17,647
New +$379K 0.44% 86

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtus ETF Advisers's GTHX Position: Q2 2022 in Review

Virtus ETF Advisers sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 15,188 shares — an estimated $115K sold.

Virtus ETF Advisers first reported a position in GTHX in Q4 2017 and held it in 18 quarters. The position peaked at $1.41M in Q1 2018. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • Virtus ETF Advisers reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 15,188 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $115K.
  • Virtus ETF Advisers first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2017 and held it in 18 quarters.
  • Virtus ETF Advisers's G1 Therapeutics, Inc. Common Stock position peaked at $1.41M in Q1 2018.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.